Episode Details
Back to Episodes
HSE approves Skyclarys reimbursement for Friedreich's Ataxia patients
Published 4 days, 7 hours ago
Description
The HSE has approved the reimbursement of the drug Skyclarys for people with Friedreich's Ataxia.
This comes following a substantially improved financial offer by drug firm Biogen to the Health Service Executive.
Joining Ciara to discuss this is Minister for Health, Jennifer Carroll MacNeill.